Europe Glycomic Therapeutics Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. Europe Glycomic Therapeutics Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. Europe Glycomic Therapeutics Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. Europe Glycomic Therapeutics Market Regional Analysis

6.2 Europe Glycomic Therapeutics Market Revenue 2020-2028 (US$ Million)

6.3 Europe Glycomic Therapeutics Market Forecast Analysis

7. Europe Glycomic Therapeutics Market Analysis – by Class

7.1 Isolated and Synthetic

7.1.1 Overview
7.1.2 Isolated and Synthetic: Europe Glycomic Therapeutics Market – Revenue and Forecast, 2020-2028 (US$ Million)

8. Europe Glycomic Therapeutics Market Analysis – by Structures

8.1 Glycoproteins

8.1.1 Overview
8.1.2 Glycoproteins: Europe Glycomic Therapeutics Market – Revenue and Forecast, 2020-2028 (US$ Million)

8.2 Targeting Sialic Acid

8.2.1 Overview
8.2.2 Targeting Sialic Acid: Europe Glycomic Therapeutics Market – Revenue and Forecast, 2020-2028 (US$ Million)

8.3 Proteoglycans

8.3.1 Overview
8.3.2 Proteoglycans: Europe Glycomic Therapeutics Market – Revenue and Forecast, 2020-2028 (US$ Million)

8.4 Targeting Glycosaminoglycans

8.4.1 Overview
8.4.2 Targeting Glycosaminoglycans: Europe Glycomic Therapeutics Market – Revenue and Forecast, 2020-2028 (US$ Million)

8.5 Glycosylphosphatidylinositol-Anchored Proteins & Heparin Based Glycans

8.5.1 Overview
8.5.2 Glycosylphosphatidylinositol-Anchored Proteins & Heparin Based Glycans: Europe Glycomic Therapeutics Market – Revenue and Forecast, 2020-2028 (US$ Million)

8.6 Targeting Glycosphingolipids

8.6.1 Overview
8.6.2 Targeting Glycosphingolipids: Europe Glycomic Therapeutics Market – Revenue and Forecast, 2020-2028 (US$ Million)

9. Europe Glycomic Therapeutics Market Analysis – by Indications

9.1 Thrombosis & Chemoprophylaxis

9.1.1 Overview
9.1.2 Thrombosis & Chemoprophylaxis: Europe Glycomic Therapeutics Market – Revenue and Forecast, 2020-2028 (US$ Million)

9.2 Anaemia

9.2.1 Overview
9.2.2 Anaemia: Europe Glycomic Therapeutics Market – Revenue and Forecast, 2020-2028 (US$ Million)

9.3 Anti-Adhesive & Anti-Inflammatory

9.3.1 Overview
9.3.2 Anti-Adhesive & Anti-Inflammatory: Europe Glycomic Therapeutics Market – Revenue and Forecast, 2020-2028 (US$ Million)

9.4 Cataracts

9.4.1 Overview
9.4.2 Cataracts: Europe Glycomic Therapeutics Market – Revenue and Forecast, 2020-2028 (US$ Million)

9.5 Gaucher's Disease

9.5.1 Overview
9.5.2 Gaucher's Disease: Europe Glycomic Therapeutics Market – Revenue and Forecast, 2020-2028 (US$ Million)

9.6 MPS-1 & IV

9.6.1 Overview
9.6.2 MPS-1 & IV: Europe Glycomic Therapeutics Market – Revenue and Forecast, 2020-2028 (US$ Million)

9.7 Cancer

9.7.1 Overview
9.7.2 Cancer: Europe Glycomic Therapeutics Market – Revenue and Forecast, 2020-2028 (US$ Million)

9.8 Alzheimer's Disease

9.8.1 Overview
9.8.2 Alzheimer's Disease: Europe Glycomic Therapeutics Market – Revenue and Forecast, 2020-2028 (US$ Million)

9.9 Influenza Type A & B

9.9.1 Overview
9.9.2 Influenza Type A & B: Europe Glycomic Therapeutics Market – Revenue and Forecast, 2020-2028 (US$ Million)

10. Europe Glycomic Therapeutics Market Analysis – by Mode of Action

10.1 Inhibits Neuraminidase

10.1.1 Overview
10.1.2 Inhibits Neuraminidase: Europe Glycomic Therapeutics Market – Revenue and Forecast, 2020-2028 (US$ Million)

10.2 Inhibits Heparanase and Selectins and Blocks Interactions Between Growth Factors and Heparan Sulfate

10.2.1 Overview
10.2.2 Inhibits Heparanase and Selectins and Blocks Interactions Between Growth Factors and Heparan Sulfate: Europe Glycomic Therapeutics Market – Revenue and Forecast, 2020-2028 (US$ Million)

10.3 Erythropoietin & Enzyme Replacement Therapy

10.3.1 Overview
10.3.2 Erythropoietin & Enzyme Replacement Therapy: Europe Glycomic Therapeutics Market – Revenue and Forecast, 2020-2028 (US$ Million)

10.4 Tissue Plasminogen Activator

10.4.1 Overview
10.4.2 Tissue Plasminogen Activator: Europe Glycomic Therapeutics Market – Revenue and Forecast, 2020-2028 (US$ Million)

10.5 Inhibits Glucosylceramide Synthas Interleukin 1 and 2 and 3

10.5.1 Overview
10.5.2 Inhibits Glucosylceramide Synthas Interleukin 1 and 2 and 3: Europe Glycomic Therapeutics Market – Revenue and Forecast, 2020-2028 (US$ Million)

10.6 Beta & Gamma Interferons

10.6.1 Overview
10.6.2 Beta & Gamma Interferons: Europe Glycomic Therapeutics Market – Revenue and Forecast, 2020-2028 (US$ Million)

10.7 Others

10.7.1 Overview
10.7.2 Others: Europe Glycomic Therapeutics Market – Revenue and Forecast, 2020-2028 (US$ Million)

11. Europe Glycomic Therapeutics Market – Europe Analysis

11.1 Overview

11.2 Europe

11.2.1 Europe Glycomic Therapeutics Market Breakdown, by Key Country, 2023 and 2028 (%)
11.2.1.1 Europe Glycomic Therapeutics Market – Revenue and Forecast Analysis – by Country
11.2.1.1 UK: Europe Glycomic Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)

11.2.1.1.1 UK: Europe Glycomic Therapeutics Market Breakdown, by Class
11.2.1.1.2 UK: Europe Glycomic Therapeutics Market Breakdown, by Structures
11.2.1.1.3 UK: Europe Glycomic Therapeutics Market Breakdown, by Indications
11.2.1.1.4 UK: Europe Glycomic Therapeutics Market Breakdown, by Mode of Action

11.2.1.2 Germany: Europe Glycomic Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)

11.2.1.2.1 Germany: Europe Glycomic Therapeutics Market Breakdown, by Class
11.2.1.2.2 Germany: Europe Glycomic Therapeutics Market Breakdown, by Structures
11.2.1.2.3 Germany: Europe Glycomic Therapeutics Market Breakdown, by Indications
11.2.1.2.4 Germany: Europe Glycomic Therapeutics Market Breakdown, by Mode of Action

11.2.1.3 France: Europe Glycomic Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)

11.2.1.3.1 France: Europe Glycomic Therapeutics Market Breakdown, by Class
11.2.1.3.2 France: Europe Glycomic Therapeutics Market Breakdown, by Structures
11.2.1.3.3 France: Europe Glycomic Therapeutics Market Breakdown, by Indications
11.2.1.3.4 France: Europe Glycomic Therapeutics Market Breakdown, by Mode of Action

11.2.1.4 Russia: Europe Glycomic Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)

11.2.1.4.1 Russia: Europe Glycomic Therapeutics Market Breakdown, by Class
11.2.1.4.2 Russia: Europe Glycomic Therapeutics Market Breakdown, by Structures
11.2.1.4.3 Russia: Europe Glycomic Therapeutics Market Breakdown, by Indications
11.2.1.4.4 Russia: Europe Glycomic Therapeutics Market Breakdown, by Mode of Action

11.2.1.5 Italy: Europe Glycomic Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)

11.2.1.5.1 Italy: Europe Glycomic Therapeutics Market Breakdown, by Class
11.2.1.5.2 Italy: Europe Glycomic Therapeutics Market Breakdown, by Structures
11.2.1.5.3 Italy: Europe Glycomic Therapeutics Market Breakdown, by Indications
11.2.1.5.4 Italy: Europe Glycomic Therapeutics Market Breakdown, by Mode of Action

11.2.1.6 Rest of Europe: Europe Glycomic Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)

11.2.1.6.1 Rest of Europe: Europe Glycomic Therapeutics Market Breakdown, by Class
11.2.1.6.2 Rest of Europe: Europe Glycomic Therapeutics Market Breakdown, by Structures
11.2.1.6.3 Rest of Europe: Europe Glycomic Therapeutics Market Breakdown, by Indications
11.2.1.6.4 Rest of Europe: Europe Glycomic Therapeutics Market Breakdown, by Mode of Action

12. Competitive Landscape

12.1 Heat Map Analysis

12.2 Company Positioning and Concentration

13. Industry Landscape

13.1 Overview

13.2 Market Initiative

13.3 Partnerships and Collaborations

13.4 Other Developments

14. Company Profiles

14.1 Intellihep Ltd

14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments

14.2 BioMarin Pharmaceutical Inc.

14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments

14.3 Genzyme Corporation (Sanofi)

14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments

14.4 Bayer AG

14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments

14.5 GlycoMar

14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments

14.6 GlaxoSmithKline plc.

14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments

14.7 F.Hoffmann-La Roche Ltd

14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments

15. Appendix

15.1 About Business Market Insights

15.2 List of Abbreviations

Europe Glycomic Therapeutics Market